期刊文献+

特应性皮炎小鼠模型皮损中MiR-155表达及血清IL-4水平的分析 被引量:4

Expression of Iesional Mi R-155 and Serumal IL-4 Level in Mouse Models of Atopic Dermatitis
下载PDF
导出
摘要 目的测定MiR-155在半抗原(2,4-二硝基氟苯)诱导C57BL/6小鼠特应性皮炎模型皮损中的表达及血清IL-4相关性。方法小鼠造模第1天背部使用0.5%DNFB外涂,第5,8,11,14天耳部及背部外涂0.2%DNFB,14天后48h内处死,后检测皮肤MiR-155相对表达量及血清IL-4的表达,并做Pearson相关性分析。结果模型组皮肤表现出明显炎症,耳部明显肿胀,病理提示表皮明显增厚、真皮炎症细胞浸润,血清检测IgE,IL-4含量明显升高(P<0.05),皮损内MiR-155相对表达量明显升高(P<0.01),皮损MiR-155相对表达量与血清IL-4呈正相关(R=0.99,P<0.01)。结论 MiR-155可能参与特应性皮炎的发病,并可能在以分泌IL-4为主的Th2细胞介导的免疫反应中发挥作用。 Objective To detect MiR-155 in lesions of atopic dermatitis induced by hapten of DNFB on a background of C57BL/6 and explore the correlation of serumal IL-4 level. Methods Topically apply the 0. 5% DNFB (day 1 ) on the dorsal skins and 0. 2% DNFB (5, 8, 11, 14 days) on the ears and dorsal skins, to test the MiR-155 expression and correlation with IL-4 in serum. Results The inflammation of the model group was obvious, and the histopathology of skin lesions showed thickness of the epidermis and the dominant infiltration of lymocytes in the dermis, and serum IgE and IL-4 were elevated significantly. The expressions of MiR- 155 were elevated in the lesions and were positively correlated with IL-4 in serum. Conclusion MiR-155 may be involved in the onset of atopic dermatitis, and may play a role in the Th2 mediated immune response featured by increased IL-4 secretion.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2016年第1期13-16,38,共5页 The Chinese Journal of Dermatovenereology
基金 国家自然科学青年基金项目(81403395) 广东省中医药强省建设专项(粤财工〔2014〕539) 广东省财政厅课题(粤财工〔2013〕62)
关键词 MIR-155 特应性皮炎 IL-4 MiR-155 Atopic dermatitis IL-4
  • 相关文献

参考文献17

  • 1Flohr C, Mann J. New insights into the epidemiology of childhood atop- ic dermatitis[J]. ALLERGY,2014,69(1SI) :3 - 16.
  • 2Xu F, Yan S, Li F, et al. Prevalence of childhood atopic dermatitis: an urban and rural community-based study in Shanghai, China [J]. PLoS One,2012,7(5) :e36174.
  • 3Lu TX, Rothenberg ME. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases [J]. J Allergy Clin Immunol, 2013, 132(1):3-13, 14.
  • 4Sonkoly E, Janson P, Majuri ML, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative respon- ses by targeting cytotoxic T lymphocyte-associated antigen 4 [J]. J Al- lergy Clin Immunol, 2010, 126(3) :581 -589.
  • 5Ralfkiaer U, Lindal L, Litman T, et al. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and ad- vanced cutaneous T-cell lymphoma [J]. Antieaneer Res, 2014, 34 (12) :7207 -7217.
  • 6Heo JC, Son HU, Kim SL, et al. A derivative of L-allo threonine alle- viates 2,4-dinitrofluorobenzene-induced atopic dermatitis indications [J]. Biosci Biotechnol Biochem,2012,76 ( 11 ) :2021 - 2025.
  • 7Nam DY, Lee JM, Heo JC, et al. Mitigation of 2,4-dinitrofluoro- benzene-induced atopic dermatitis-related symptoms by Terminalia che- bula Retzius[J]. Int J Mol Med,2011,28(6) :1013 -1018.
  • 8Heo JC, Nam DY, Seo MS, et al. Alleviation of atopic dermatitis-relat- ed symptoms by Perilla frutescens Britton[J]. Int J Mol Med,2011,28 (5) :733 -737.
  • 9Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T) ( -Delta Delta C) method [ J]. METHODS,2001,25 (4) :402 - 408.
  • 10Kitagaki H, Ono N, Hayakawa K, et al. Repeated elicitation of con- tact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile [ J ]. J Immunol, 1997,159 (5) :2484 - 2491.

二级参考文献25

  • 1Boguniewicz M,Leung Donald YM. AtopicDermatitis:a disease of altered skin barrierand immune dysregulation [J] . ImmunolRev,2011,242(1):233-246.
  • 2Saifur R,Mary C, Cara MMW, et al. Thepathology and immunology of atopic dermati-tis[J]. Inflammation & Allergy-Drug Tar-gets,2011 ,10(6):486-496.
  • 3Jin HI, He R, Oyoshi M,et al. Animal mod-els of atopic dermatitis [J]. Journal of Inves-tigative Dermatology,2009,129(1):31-40.
  • 4Spergel J, Mizoguchi E, Brewer J,et al. Ep-icutaneous sensitization with protein antigeninduces localized allergic dermatitis and hy-perresponsiveness to metacholine after singleexposure to aerosolized antigen in mice [J].Clin Invest, 1998,101(8):1614-1622.
  • 5Ge J. probiotics in primary prevention ofAtopic dermatitis [J] . Food Factors forHealth Promotion, 2009 ,61:117-128.
  • 6Huang CH, Kuo IC , Xu H, et al. Mite al-lergen induces allergic dermatitis with con-comitant neurogenic inflammation in mouse[J]. Invest Dermatol,2003,121(2):289-293.
  • 7Matsumoto K, Mizukoshi K, Oyobikawa M,et al. Establishment of an atopic dermatitis-like skin model in a hairless mouse by re-peated elicitation of contact hypersensitivitythat enables to conduct functional analysesof the stratum comeum with various non-in-vasive biophysical instruments [J] . SkinRes Technol,2004,10(2):122-129.
  • 8Suwa E,Katsunori Y,Oda M, et al. Hista-mine H4 receptor antagonist reduces dermalinflammation and pruritus in a hapten-in-duced experimental model [J] . EuropeanJournal of Pharmacology, 2011,667( 1-3):383-388.
  • 9Laouini D, Kawamoto S, Yalcindag A, etal. Epicutaneous sensitization with superan-tigen induces allergic skin inflammation[J]. Journal of Allergy and Clinical Immu-nology,2003 ,112(5):981-987.
  • 10Lehtoa M, Savinkoa T, Wolff H,et al. Amurine model of epicutaneous protein sen-sitization is useful to study efficacies of top-ical drugs in atopic dermatitis[J]. Interna-tional Immunopharmacology ,2010,10(4):377-384.

共引文献5

同被引文献39

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部